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α-Synuclein is a presynaptic protein associated to Parkinson’s disease, which is unstructured when free 
in the cytoplasm and adopts α helical conformation when bound to vesicles. After decades of intense 
studies, α-Synuclein physiology is still difficult to clear up due to its interaction with multiple partners 
and its involvement in a pletora of neuronal functions. Here, we looked at the remarkably neglected 
interplay between α-Synuclein and microtubules, which potentially impacts on synaptic functionality. 
In order to identify the mechanisms underlying these actions, we investigated the interaction between 
purified α-Synuclein and tubulin. We demonstrated that α-Synuclein binds to microtubules and tubulin 
α2β2 tetramer; the latter interaction inducing the formation of helical segment(s) in the α-Synuclein 
polypeptide. This structural change seems to enable α-Synuclein to promote microtubule nucleation 
and to enhance microtubule growth rate and catastrophe frequency, both in vitro and in cell. We also 
showed that Parkinson’s disease-linked α-Synuclein variants do not undergo tubulin-induced folding 
and cause tubulin aggregation rather than polymerization. Our data enable us to propose α-Synuclein 
as a novel, foldable, microtubule-dynamase, which influences microtubule organisation through its 
binding to tubulin and its regulating effects on microtubule nucleation and dynamics.
Microtubules (MTs) are dynamic polymers consisting of α β tubulin dimers, which play an essential role in cell 
shape acquisition and many intracellular processes1. In large cells, such as neurons, little is known about how 
MTs can nucleate in the axonal compartment, far away from the MT-organizing center in the cell body. Further, 
to date, the regulation of the MT dynamics underlying synaptic functions is still elusive. Many MT-interacting 
proteins are believed to regulate these phenomena; for example, dispersed γ tubulin complexes are reliable nucle-
ating structures in the axon2.
Nowadays, there is increasing evidence for a direct interplay between MTs and α -Synuclein (Syn), a presynap-
tic unfolded protein widely expressed in brain tissues3. Despite the controversial issues on its physiology, Syn has 
been clearly associated with neurodegeneration. Indeed, Syn overproduction due to multiplications of the SNCA 
locus encoding for Syn and point mutations in the gene itself cause familial forms of Parkinson’s disease (PD)3. 
The underlying pathogenic mechanism is still unclear. Cytotoxicity is currently attributed to Syn oligomers4, 
whose overexpression induces MT disruption in cells5. Furthermore, tubulin is known to promote Syn fibrillation 
in vitro6, although it is not clear whether destabilization of the MT cytoskeleton potentiates7 or prevents8 Syn 
aggregation in vivo.
Even though many efforts have been devoted to the identification of a link between tubulin and Syn in patho-
logical contexts, their physiological interaction has been largely ignored. Alim and colleagues9 have revealed that 
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wild type (WT) Syn promotes MT assembly, whereas Chen and colleagues have claimed that neither monomeric 
nor oligomeric Syn influences MT polymerization in vitro10. Co-immunoprecipitation studies as well as affinity 
chromatography have also revealed a direct interaction between Syn and free tubulin11, but it is still unclear 
whether Syn forms a complex with tubulin dimers or with higher-order assemblies.
Here we analyse the interaction between Syn and tubulin and we clear up the physiological relevance of the 
interaction between Syn and MTs. We found that WT Syn undergoes a structural change upon tubulin binding, 
promoting both microtubule nucleation and dynamics. Furthermore, our data obtained with PD-related Syn 
mutants provide hints for the pathogenic mechanism in PD.
Results
Syn binds to MTs and folds upon interaction with the tubulin α2β2 tetramer. In order to investi-
gate the mechanism by which Syn regulates MT cytoskeleton and to determine whether Syn interacts with tubulin 
dimer or with higher-order assemblies, we studied the interaction between purified Syn and tubulin in vitro. First 
of all, we performed co-sedimentation assay (Fig. 1a,b, and Supplementary Fig. S1), an approach which allows 
investigating the capability of a protein to bind polymerized and stabilized MTs12, showing that Syn interacts with 
preformed MTs (Fig. 1a). The plot of [Syn]bound versus [Syn]free (Fig. 1b), which was fitted by nonlinear regression 
to a standard binding equation, enabled us to calculate an apparent Kd of 7.48 ± 1.38 μ M, which is indicative 
of loose binding between Syn and MTs. In addition, differential interference contrast (DIC) and fluorescence 
microscopy analyses confirmed that WT Syn co-polymerizes with MTs (Supplementary Fig. S2), as revealed by 
Syn staining along conventional MTs polymerized in the presence of Syn. We also verified the ability of Syn to 
co-purify with brain tubulin9; two purification batches of tubulin were analysed by western blotting using anti-
Syn antibodies and resulted to be positive for Syn staining, thus confirming that Syn co-purifies with tubulin 
(Supplementary Fig. S2). As the tubulin purification involves cycles of polymerization and depolymerization in 
conditions that should remove the majority of the MT-associated proteins13, this result reinforces the idea that 
Figure 1. WT Syn interacts with preformed MTs and tubulin α2β2 tetramer. (a) Representative Western 
blotting of Syn (0–32 μ M) recovered in the supernatant (S) or pellet (P) fraction from co-sedimentation assays 
without (Syn) or after (Syn + MTs) incubation with preformed MTs (Tub) at constant total MT concentration 
(4 μ M tubulin dimers). (b) Bound Syn plotted versus free Syn (r2 = 0.94). The data reported in the plot derive 
from at least three different replicates. (c) Nano-ESI-MS spectra of 14 μ M tubulin: the peak distributions relative 
to the tubulin dimer and the α 2β 2 tetramer are grouped by brackets, with the indication of the measured mass. 
(d) Overlay of spectra of 14 μ M tubulin (black), and a mixture of 14 μ M tubulin and 14 μ M Syn (red), in the m/z 
range 4000–5200 (α β dimer) or (e) in the m/z range 5600–7000 (α 2β 2 tetramer). The peaks corresponding to 
the α 2β 2/Syn complex are labelled by asterisks. (f) Magnification of panel e, in the m/z range 6100–6500. The 
arrows point to the peaks of the α 2β 2/Syn complex, labelled by the corresponding charge state. The measured 
mass of the complex is also indicated. In each panel, the most intense peak of each distribution is labelled by the 
corresponding charge state.
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Syn can interact also with unpolymerized tubulin11. Thus, we investigated the direct interaction between Syn 
and free tubulin dimers by using native mass spectrometry (MS) and nano-electrospray ionization (nano-ESI). 
The spectra of 14 μ M tubulin and a mixture of 14 μ M tubulin and 14 μ M Syn (black and red spectra, respectively, 
in Fig. 1c–f) reveal that Syn forms a specific complex with the tubulin α 2β 2 tetramer. The measured mass of this 
complex (217.8 kDa) was in agreement with the calculated one for a complex of two tubulin dimers (α 2β 2) and 
one Syn molecule. Moreover, the average charge (34.5+ ) of the complex is close to the expected value for a globu-
lar protein of the same mass (36.1+ )14, suggesting that the complex itself has a compact conformation. However, 
bound Syn does not necessarily have a globular conformation but it can wrap around the tubulin tetramer in an 
ordered, but extended conformation. To address this issue, we studied potential conformational changes resulting 
from tubulin/Syn interaction by far UV circular dichroism (CD). Our data confirmed that Syn is unfolded in the 
absence of the ligand, whereas an equimolar Syn/tubulin mixture gives an overall secondary structure CD signal, 
which is more intense than the sum of the signals of the two individual proteins (Fig. 2a). Moreover, the CD signal 
originating in the mixture shows a gain of signal at 220 nm, which is typical of α -helix structures. Considering 
that (i) the interaction of tubulin with ligands is widely studied and an increase in its α -helix content has never 
been observed, and (ii) Syn is a soluble, intrinsically unfolded protein which is able to adopt α -helix structure in 
adequate conditions15–17, we hypothesize that, upon its interaction with tubulin, Syn folds into a structure which 
is rich in α -helix content. Such a secondary structural transition is reminiscent of the conformational changes 
associated with the RB3-stathmin like domain (RB3-SLD) upon interaction with tubulin18 (Fig. 2b). According 
to the hypothesis that Syn/tubulin interaction induces α -helical structures in Syn, the CD spectra of Syn com-
plexed with tubulin has been extrapolated (Fig. 2a, solid black line, differential spectrum obtained by subtracting 
the tubulin spectrum from the one of the complex) and the related α -helix content estimated to 35%. It is worth 
remembering that such helical content should not reflect the amount of α -helix in a single folded molecule, but 
rather the average content of α -helix in the whole sample, taking into account both the Syn folded molecules 
which interact with tubulin and the unfolded ones remaining free in solution. The formation of a Syn/tubulin 
complex in solution, at neutral pH, has been also investigated by 1H-NMR diffusion measurements approach 
(Fig. 2c). Tubulin alone had a diffusion coefficient (D = 0.37 × 10−10 m2sec−1) consistent with the presence of α 
β dimers in solution, whereas Syn showed a value (D = 0.83 × 10−10 m2sec−1) smaller than the one expected for a 
globular ~14 kDa protein and consistent with the presence of unfolded species19. In the presence of tubulin, the 
diffusion coefficient measured for Syn significantly decreased from 0.83 × 10−10 m2sec−1 to 0.59 × 10−10 m2sec−1. 
This clearly indicates the formation of a complex between these proteins. However, since the measured value is 
actually less than that one expected for a stable 1:1 complex, it should be concluded that, at least in our conditions, 
a certain fraction of Syn still remains in its free state in solution and that the Syn molecules exchange between the 
free and bound states at a rate which is fast compared to both the NMR chemical shift and diffusion measurement 
time scales (fast exchange limit, kex < 100 sec−1). The fraction of free Syn has been estimated within the 45–55% 
range, leading to a Syn/tubulin dissociation constant between 10 and 20 μ M, which is in agreement with the data 
obtained by the co-sedimentation assay (Fig. 1).
Figure 2. WT Syn interacts with tubulin and acquires secondary structure. (a) Far UV CD spectra of 
isolated 14 μ M WT Syn (dashed black line, Syn alone), isolated 14 μ M tubulin (dashed grey line, Tub alone),  
14 μ M WT Syn in the presence of equimolar tubulin (solid grey line, Tub + Syn) and differential spectra (solid 
black line, differential spectrum, [Tub + Syn] – Tub Alone). (b) Far UV CD spectra of isolated RB3-SLD 
(dashed line, RB3 alone) and differential spectra of 7 μ M RB3-SLD in the presence of 14 μ M tubulin (solid line, 
differential spectrum, [Tub + RB3] – Tub Alone). (c) 1H-NMR diffusion coefficient measurements at 25 °C 
from 2D-DOSY projections of 27 μ M Syn (Syn), Syn/tubulin equimolar mixture ([Syn]/[TUB] = 1) and 27 μ M 
tubulin (TUB).
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Altogether, our data provide a relatively detailed insight into the binding of Syn to tubulin and MTs, demon-
strating, for the first time, the formation of a complex between Syn and the tubulin α 2β 2 tetramer, and enabling 
us to posit a Syn folding step.
Folded Syn promotes MT nucleation and increases MT dynamics. Until now, the effects of Syn on 
MT polymerization have been studied without pre-incubating Syn and tubulin dimers9,10. On the other hand, 
our CD results (Fig. 2) indicate that during the period of the analyses (performed on a time scale of 5–10 min 
at 20 °C) Syn folds. Thus, we incubated Syn for 10 min at 20 °C with tubulin in order to allow Syn conforma-
tional rearrangement prior to carefully analyse tubulin assembly kinetics using a standard tubulin:protein ratio 
of 8:1 (Fig. 3a,b). We found that Syn molecules that have not been pre-incubated with tubulin did not influence 
Figure 3. Folded Syn promotes MT nucleation in vitro. (a) Tubulin assembly was recorded over time 
by measuring the increase in absorbance variation (Δ A) at 350 nm. Tubulin (40 μ M) was polymerized in 
the absence (CONT) and in the presence of 5 μ M of naïve (Syn w/o preincubation) or preincubated (Syn 
preincubated with tubulin) WT Syn. (b) Parameters describing nucleation (P, *p = 0.031 vs CONT and 
#p = 0.002 vs Syn w/o preincubation), initial velocity (Vi, *p = 0.018 vs CONT and #p = 0.033 vs Syn w/o 
preincubation) and absorbance variation (Δ A, *p = 0.0016 vs CONT and #p = 0.028 vs Syn w/o preincubation) 
were calculated from polymerisation kinetics analysis. Values are expressed as mean ± SEM (at least five 
independent experiments). *p < 0.05 vs CONT, according to ANOVA, Fischer post hoc test. (c) Final Δ A, 
obtained at various initial tubulin concentrations, were plotted against tubulin concentration. The tubulin 
critical concentration (arrows, x-intercept of fitting lines) was calculated in the absence (CONT, black) and 
in the presence of 5 μ M WT Syn (Syn, blue). Plotted values are mean ± SEM (at least three independent 
experiments). (d) Electron microscope images of MTs assembled (40 μ M Tubulin) in the absence (CONT) or 
in the presence of 5 μ M WT Syn (Syn). Scale bar, 200 (left) and 100 nm (right). (e) MT length measurements 
during the initial phase of tubulin polymerization (40 μ M) in the absence (CONT, black) and in the presence 
of 5 μ M of WT Syn (Syn, blue). Actual p values are 5.1 × 10−14 (240 sec), 2.4 × 10−17 (360 sec) and 2.3 × 10−7 
(480 sec). (f) MT length measurements in similar conditions at steady state (*p= 3.12 × 10−13). MT number is 
at least 600 for each condition, obtained from two independent experiments. *p < 0.05 vs CONT, according 
to Student’s t-test. (g) Quantification over time of the number of MT assembled with WT Syn. Values 
(mean ± SEM) are expressed as a percentage of the control experiment (without Syn). At least 15 fields obtained 
from two independent experiments were analysed for each condition (see Supplementary Fig. S2). *p < 0.05 vs 
CONT, according to Student’s t-test, performed on the raw data. Actual p are 0.024 (6 min), 0.002 (8 min), 0.042 
(64 min).
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tubulin kinetics. By contrast, pre-incubated Syn strongly impacts MT assembly (Fig. 3a) by reducing by half the 
initial velocity of polymerization (Vi) and the MT assembly at the plateau (Δ A), as shown in Fig. 3b. Next, by 
plotting log(A(t)/A∞ ) against log(t) we extrapolated the parameter P, which is indicative of the successive steps 
during the nucleation phase20, and is significantly decreased compared to tubulin alone (Fig. 3b). The effect of 
pre-incubated Syn on P value and its concomitant ability in significantly reducing tubulin critical concentration 
(Fig. 3c), underscored the ability of folded Syn to nucleate MTs. We confirmed the presence of MTs in these 
conditions by electron microscopy and negative staining analysis (Fig. 3d). We next estimated the length and the 
number of MTs assembled in the presence of folded Syn, which revealed that Syn induces the formation of shorter 
and more abundant MTs with respect to controls (Fig. 3e–g, see also Supplementary Fig. S3). The significant 
increase of MT number perfectly agrees with the induction of MT nucleation. However, the significant reduction 
of the MT mean length also suggests that, besides stimulating MT nucleation, Syn should reduce MT elongation, 
either by slowing down MT growth rate or increasing catastrophe frequency, as strongly supported by the reduc-
tion in the initial velocity of polymerization. Notably, this would explain the decrease in total polymer mass (Δ A 
in Fig. 3a,b and Supplementary Fig. S3), which is in contrast to the expected effect of a nucleation inducer.
Thus, we used video-enhanced differential interference contrast (VE-DIC) light microscopy to clear up the 
effects of WT Syn on MT dynamics (Table 1). Tubulin (10 and 15 μ M) was assembled from purified axonemes, in 
the absence or in the presence of increasing concentrations of Syn (0–15 μ M). These protein to protein ratios are 
comparable to those observed in vivo, since the actual cellular concentration of tubulin is up to 40 μ M21 and the 
estimated presynaptic Syn concentration varies between 30 and 60 μ M in neurons22. At low tubulin concentration 
(10 μ M), Syn enhanced catastrophe frequency, 4 to 6.5-fold in comparison to the control. A similar, albeit smaller, 
effect was observed at the highest tubulin concentration (15 μ M), with a 3-fold increase in the catastrophe fre-
quency in the presence of Syn compared to tubulin alone. With the two highest Syn concentrations (10 and 15 μ M), 
we also noticed a significant increase in the MT growth rate in the presence of 15 μ M tubulin. These results would 
indicate that Syn increases MT dynamics by speeding up the growth rate and promoting catastrophe events. In 
order to confirm these data in a neuronal cell line we used differentiated rat PC12 cells, which naturally express 
rat Syn starting from 7th day of NGF treatment23. We transfected PC12 cells with a construct coding for human 
Syn and treated them with NGF for three days. As shown in Fig. 4a, parental PC12 cells lack of endogenous Syn 
whereas transfected ones express human WT Syn. First of all, we confirmed the well-known interaction of Syn 
with β III-tubulin5, either in PC12 cells overexpressing human Syn (Supplementary Fig. S4) or in human neu-
rons derived from embryonic stem cells expressing the endogenous Syn (Supplementary Fig. S5). In addition, 
we highlighted a high degree of co-localization with tyrosinated α -tubulin, which is associated with the most 
dynamic MTs. Thus, to directly investigate MT dynamics in cells, we performed live cell imaging taking advantage 
of end-binding protein 3 (EB3)-mCherry24, a fluorescent protein that specifically binds growing MT plus-ends. 
We visualized MT dynamics under basal conditions (cells kept at 37 °C) or during the MT recovering phase 
(rewarming at 37 °C), which follows a cold-treatment (30 min at 4 °C), in differentiated PC12 cells co-expressing 
EB3-mCherry and GFP-Syn or GFP alone (Fig.4). This approach shows that Syn increases the number of detecta-
ble growing MTs per neurite (Fig. 4c), even though the analysed surfaces do not change (Supplementary Fig. S6), 
and thus demonstrates that Syn favours MT (re)nucleation in cell. Moreover, Syn accelerates MT growth (Fig. 4d) 
and reduces MT lifetime (Fig. 4e). The latter observation is consistent with the enhancement of the catastrophe 
frequency reported by VE-DIC microscopy (Table 1). Altogether, our data demonstrate that, upon interaction 
Tub 10 μM Tub 15 μM
Syn 0 μM Syn 5 μM Syn 10 μM Syn 0 μM Syn 5 μM Syn 10 μM Syn 15 μM
Vgrowth (μ m/min)
1.2 ± 0.1 1.38 ± 0.5 1.08 ± 0.18 1.1 ± 0.086 1.17 ± 0.14 1.38 ± 0.14* 1.32 ± 0.24*
n = 1097 n = 362 n = 395 n = 1420 n = 663 n = 695 n = 973
Vshrinkage (μ m/min)
8.7 ± 2.24 7.35 ± 2.1 7.5 ± 1.65 11 ± 1.77 8.6 ± 2 11.7 ± 2.6 8.5 ± 2.24
n = 357 n = 209 n = 309 n = 287 n = 216 n = 298 n = 336
Fcatastrophe (min−1)
0.16 ± 0.05 1.04 ± 0.3 0.69 ± 0.17 0.09 ± 0.03 0.27 ± 0.07 0.26 ± 0.07 0.22 ± 0.06
n = 9 n = 12 n = 15 n = 9 n = 14 n = 12 n = 11
Frescue (min−1)
0.15 0.67 ± 0.33 0.33 ± 0.19 0.1 0.6 ± 0.26 0.44 ± 0.22 1.26 ± 0.44
n = 1 n = 4 n = 3 n = 1 n = 5 n = 4 n = 8
Growth Duration (s) 3327 692 1304 5797 3056 2751 2944
Shrinkage Duration (s) 382 356 537 594 512 540 380
MT number 32 14 16 41 22 25 20
Table 1. Folded Syn increases MT dynamics in vitro. Dynamic parameters were determined by VE-DIC 
light microscopy for MTs assembled from purified axonemes in the presence of tubulin (10 and 15 μ M) and 
increasing concentrations of Syn (0–15 μ M). In each condition, Syn was preincubated with tubulin prior the 
observation at 37 °C. Velocities are expressed as mean ± SEM. The total growth and shrinkage times analysed, 
as well as the number of MTs used for each condition, are given in the last three rows. Catastrophe and rescue 
frequencies were calculated by dividing the total number of events by the time spent in growth and shrinkage, 
respectively. The standard deviation is calculated by dividing Fcatastrophe or Frescue by √ n assuming a Poisson 
distribution55. (n) represents the total number of measurements for the growth and shrinkage rates, and the 
total number of observed events for the catastrophe and rescue frequencies. *p < 0.05 vs Syn 0 μ M, according to 
ANOVA, Dunnett post hoc test. Actual p are 0.005 (Syn 10 μ M) and 0.0051 (Syn 15 μ M).
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with the tubulin α 2β 2 tetramer, Syn acquires helical structure and becomes able to govern multiple steps of MT 
assembly and dynamics, such as nucleation, growth rate and catastrophe frequencies, in a purified system as well 
as in a neuronal cell model.
Syn displays sequence similarity to stathmin. Syn displays striking structural and functional similar-
ities with the tubulin-interacting protein stathmin. Both of them are about 14-15 kDa, intrinsically disordered 
proteins and capable of adopting α -helix conformation upon interaction with binding partners18,25 (Fig. 2a). It 
is noteworthy that Syn, like stathmin and RB3-SLD, interacts with the tubulin α 2β 2 tetramer and promotes MT 
catastrophes. Thus, we explored sequence similarities between Syn and the members of the stathmin family. 
Pairwise alignment of WT Syn to stathmin showed about 20% identical residues and over 50% conservative 
substitutions. Two possible tubulin-interacting domains have been proposed for Syn but the pathological point 
mutations, which impair the tubulin binding, are outside the suggested regions9,26. Therefore, searching for a 
tubulin-related physiological relevance for the region including the mutations, we decided to align two 21-residue 
stretches surrounding the residues 30 or 53 in the Syn polypeptide chain (Fig. 5). Interestingly, the fragment 
centered around Syn residue 53, in which four of the five PD-linked point mutations are clustered27, aligned to 
one of the functionally relevant regions of the stathmin family (Fig. 5, blue lines), namely the tubulin-binding 
domains28. This region displays multiple invariant residues (Fig. 5 asterisks), including the sites of the Syn patho-
logical mutations A53T and E46K (Fig. 5, red arrows), besides several other conservative or semi-conservative 
substitutions (Fig. 5, colons and dots, respectively). Furthermore, we completed the analysis in order to align the 
entire region 1–100 of Syn polypeptide chain to the stathmin-family (Supplementary Fig. S7), since we suggest 
that Syn acquires an α -helical structure (Fig. 2) and this is the domain of Syn that folds upon interaction with ves-
icle. As the two domains reported in Fig. 5 showed a good conservation, we anchored them and aligned the other 
stretches of Syn to the remaining regions of the stathmin-family. These regions display a very poor conservation 
and, thus, this result reinforces the idea that the region around the pathological mutations might be important 
for binding to tubulin and that its point mutations likely compromise Syn/tubulin interaction. All these data 
demonstrate that Syn and stathmin share physicochemical and functional properties, and the good alignment 
Figure 4. WT Syn increases MT dynamics in neuronal cells. (a) Representative western blot showing the 
levels of expression of human Syn (Syn) in 5 days NGF-differentiated control (GFP) and transfected (Syn) PC12 
cells. The antibody used (Sigma-Aldrich) recognized both human and rat Syn. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) is used as loading reference. (b) Representative micrographs of double transfected 
PC12 cells differentiated 3 days with NGF, showing the EB3 comets (EB3-mCherry, inverted contrast) and, 
in the inset, the GFP channel (GFP, grey line marks the cell boundary). The grey box indicates the area from 
which the frames of the time series were taken (elapsed time is shown). Scale bar, 5 μ m. Box plots of the 
number (c, *BASAL = 0.007, *RECOVERY = 0.005), speed (d, *BASAL = 0.02, *RECOVERY = 0.007) and lifetime 
(e, *BASAL = 0.02, *RECOVERY = 0.02) of MT growths, in each experimental condition. BASAL indicates 
cell cultures maintained at 37 °C whereas RECOVERY indicates registration during the rewarming phase after 
30 min at 4 °C. At least 30 cells were analysed per condition, for a total number of 2200 tracks, or more. *p < 0.05 
vs GFP, according to Student’s t-test. The analyses of the relative neurite’s area are reported in Supplementary 
Fig. S5.
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of the fragment 43–63 of Syn with a functionally relevant region of stathmins strongly indicates that Syn and 
proteins belonging to the stathmin-family may be involved in same biological processes, such as the regulation 
of MT cytoskeleton.
Pathological Syn mutations corrupt Syn/tubulin interaction. Having shown that four out of five 
PD-linked mutations map to the putative tubulin-binding domain of Syn (Fig. 5), these substitutions are expected 
to have a profound effect on Syn interaction with tubulin and, reasonably, on tubulin-induced folding of Syn. 
Indeed, CD analyses revealed that the A53T variant is much less sensitive than WT Syn to the structuring effect 
of tubulin (Fig. 6a, red lines) whereas the E46K mutant loses almost completely the ability to fold in the presence 
of tubulin (Fig. 6a, green lines). Although the pathological A30P mutation mapped far away from the putative 
tubulin-interacting domain we proposed (Fig. 5), this amino acid substitution has the potential to interfere with 
tubulin-induced folding of Syn, as confirmed by CD analyses (Fig. 6a, blue lines). In order to verify that mutated 
Syns used in the assays were not aggregated, thus to avoid unwanted effects on tubulin assembly, we analysed 
them by size exclusion chromatography. We observed a single peak for all the Syn corresponding to a molar mass 
of 14 kDa (Supplementary Fig. S8), which indicates the presence of monomeric Syn. Moreover, we observed that 
MTs assembled in the presence of Syn mutants (all pre-incubated with tubulin) are crowded and surrounded 
by abundant protein aggregates (Fig. 6b and Supplementary Fig. S2), which were not present at the beginning 
of the experiments (see size exclusion chromatography results, Supplementary Fig. S8) but rather are formed 
during the incubation. These aggregates should be composed of both tubulin and Syn; indeed, very few and 
small aggregates are observed both in control conditions, i.e. without adding Syn, meaning that they are made 
of tubulin, and in the presence of WT Syn (Supplementary Fig. S8). Since aggregates in the presence of mutated 
Syns (Supplementary Fig. S8) are also recognized by the Syn antibody (Supplementary Fig. S2), they should 
contain Syn. Interestingly, the aggregation propensity of the mutated Syns seems to be inversely proportional to 
their ability in folding in the presence of tubulin (Fig. 6a and Supplementary Fig. S8). Therefore, our data reveal 
that Syn mutants are much less sensitive than WT Syn to tubulin-induced folding and mainly promote tubulin 
aggregation. This could potentially impair the correct organization of the MT system impacting on the neuronal 
processes in which MTs and Syn are implicated.
Discussion
As stated by Feng and Walsh29 a decade ago: “Protein-protein interactions are a little like human relationships. 
Some are dedicated, faithful and lifelong, while other relationships are brief flings with a promiscuous variety 
of partners that may leave no lasting trace or may induce profound changes”. Here we show that the interplay 
between Syn and tubulin is a multifaceted protein-protein interaction. Indeed, their encounter triggers the struc-
tural rearrangement of Syn which, in turn, regulates the birth, the growth and the lifespan of individual MTs. 
Therefore, we set forth the hypothesis that Syn is a MT “dynamase”, a term introduced by Erent and colleagues30 
for Kinesin-8, which is able to regulate both MT nucleation and catastrophes in S. pombe, exactly what Syn does, 
regulating nucleation, growth rate and catastrophe frequency of MTs, in vitro and in cell.
MTs exhibit non-equilibrium dynamics, which depends on free-tubulin concentration. In cell systems, a con-
stant free tubulin concentration, and the presence of a multitude of MT-interacting proteins likely buffers and mit-
igates perturbations in MT dynamics, conferring a degree of robustness and homeostasis to the MT cytoskeleton31. 
Nevertheless, stressful conditions exist (i.e. neuronal aging) and under these conditions the free tubulin con-
tent may considerably change. When tubulin concentration is high, the initial response of a MT-associated 
protein will be potent and it would induce MT assembly, as we observe at the beginning of assembly kinetics 
in the presence of Syn (Fig. 3) or in VE-DIC experiments performed at high tubulin concentrations (Table 1). 
In the mechanistic model we propose, the ability of WT Syn to interact with the tubulin α 2β 2 tetramer ena-
bles Syn to fold (Fig. 7, STEP 1) and, possibly, to act as a tubulin carrier by delivering small tubulin oligomers 
(α 2β 2 tetramers), which have been recently proposed, although it is controversial, to promote MT nucleation 
and MT elongation32–34. Thus, Syn could either crosslink tubulin heterodimers, inducing nucleation (Fig.7, 
STEP 2-high [Tub]free), and/or stabilize them in a favourable orientation promoting supramolecular interactions 
involved in MT formation. As net polymerization is promoted, the free tubulin concentration drops down, mit-
igating the assembly-inducing activity of Syn, as observed at the steady state of assembly kinetics (Fig. 3) or with 
Figure 5. Syn displays sequence similarities with stathmin. Multiple alignment of Syn with four members 
of stathmin family was performed by ClustalW. Blue lines delimitate the domains of stathmin family involved 
in tubulin binding. Arrows mark the sites of Syn pathological mutations: Ala30 (green arrow), the conserved 
Glu46 and Ala53 (red arrows), His50 and Gly51 (blue arrows). Asterisks mark invariant positions, while dots 
and colons highlight semi-conservative and conservative substitutions, respectively.
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low tubulin concentrations in VE-DIC experiments (Table 1), when catastrophe stimulation prevails. How are 
these catastrophe events induced? Two possible mechanisms have been proposed for the catastrophe-promoting 
activity of stathmin35: (i) sequestering of soluble tubulin into assembly-incompetent tubulin/stathmin complexes, 
which has the same stoichiometry of Syn/tubulin complexes identified in the present study (Fig. 1), or (ii) direct 
binding of stathmin to MT ends, which would increase the frequency of switching from growth to shortening. It 
is unlikely that Syn acts by sequestering tubulin dimers, since such a phenomenon would reduce MT growth rate, 
in contrast to our observations (Table 1). We hypothesize that, once bound to the MT lattice, Syn could affect the 
whole stability of the polymer by inducing conformational changes in the intra- or inter-dimer angle and thus 
amplifying the intrinsic tendency of MTs to undergo catastrophes (Fig. 7, STEP 2-low [Tub]free). Nevertheless, 
further studies are needed to definitively solve the mechanism by which Syn promotes MT catastrophes.
Here, we also demonstrated that PD-linked Syn variants do not exhibit α -helical folding upon tubulin binding 
and induce tubulin aggregation. A30P mutation is located on the short helix of the lipid-folded Syn27, and the fact 
that the polypeptide region including this mutation is not part of the putative tubulin-interacting domain could 
explain why it is the most “benign” PD point mutation36. Conversely, the other 4 described point mutations of Syn 
(E46K, H50Q, G51D and A53T) fall inside a region corresponding to the tubulin-interacting domain of proteins 
belonging to the stathmin family. We are aware that this region maps outside the tubulin-binding regions previ-
ously proposed for the WT9,26., which seem to be unique for Syn and do not share homology with other known 
tubulin-interacting proteins. Nevertheless, the two previously reported binding domains are diverse, sharing only 
4 residues and completely excluding the region in which there are the pathological mutations. Alim and col-
leagues9, tried to justify the tubulin-aggregating effect of the A30P and A53T mutants saying that these mutations 
can alter the Syn folding, exactly what we showed here (Fig. 6). Our results propose an alternative tubulin-binding 
domain that well matches with the ones of the stathmin-like proteins, and which also includes most of the 
reported pathological mutations. Future work on pre-incubated Syn fragments will be necessary to validate this 
as tubulin-binding domain. Thus, our data provide mechanistic insights into the molecular pathology of PD, 
Figure 6. Pathological Syn mutations corrupt Syn/tubulin interaction. (a) Far UV CD spectra of 14 μ M 
mutated Syns, A30P (blue lines), A53T (red lines) and E46K (green lines), obtained with naïve proteins (dashed 
lines, alone) or by the difference between the spectrum of Syns in the presence of equimolar amount of tubulin 
minus the spectrum of tubulin alone (solid lines, differential spectrum). (b) Electron microscope images of MTs 
assembled in vitro (40 μ M tubulin) in the presence of 5 μ M of WT (WT) or mutated (A30P, A53T and E46K) 
Syns. Scale bars, 200 (top) and 100 nm (bottom).
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which would involve MT-dependent pathways. Indeed, tubulin aggregation induced by mutated Syns (Fig. 6, 
Supplementary Fig. S2, Supplementary Fig. S8 and Alim et al.9), could lead to excessive MT bundles, engulf-
ing axons and impairing intracellular transport, as previously described for other neurodegenerative disease37. 
Therefore, axonal transport disruption could be the missing link between Syn/tubulin interaction and PD. In 
accordance, a very recent paper showed that Syn oligomers, the most toxic Syn species, reduce MT stability, 
kinesin/MTs interplay and neuritic kinesin-dependent cargoes, promoting early neurite pathology5. Although 
alteration of axonal transport is considered as one of the earliest events in neurodegeneration38, we showed 
that it follows MT dysfunction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine-induced model of PD39,40. 
Hence, by affecting axonal transport, MT dysfunction may trigger the chain of events leading to PD. Accordingly, 
MT-targeted molecules have beneficial effects in both 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine-treated40 
and Syn-overexpressing41 mice and the correction of MT defects rescues control phenotype and cell homeostasis 
in PD patient derived cell lines42–44. Therefore, by providing insights into the interaction between Syn and MTs, 
our data would highlight some essential steps in neuronal function and degeneration.
Many controversial issues remain to be clarified, such as solving the puzzle of the actual naïve state of Syn: is 
it a folded tetramer45 or a labile unstructured monomer16? Nevertheless, here we have demonstrated that mon-
omeric WT Syn forms a specific complex with the tubulin α 2β 2 tetramer, acquiring a defined secondary struc-
ture. We could speculate that local accumulation (i.e. at the pre-synapse) of free tubulin dimers would change 
the equilibrium between unfolded and folded/tetrameric Syn, which may have evolved to act as a sensor of the 
tubulin dimers/MTs ratio. Thus, the increase in tubulin dimers concentration and the consequent folding of Syn 
molecules start the Syn-mediated regulation of both MT nucleation and dynamics, as we have demonstrated 
here. Therefore, we propose that Syn can be considered a MT dynamase, which potentially set MT mass at the 
pre-synapse.
Figure 7. Model for Syn/MTs interaction. Syn senses and binds free tubulin dimers forming a specific 
complex with tubulin α 2β 2 tetramer and acquiring α -helix conformation (STEP 1). Afterwards, Syn behaves 
like a tubulin deliverer promoting MT nucleation (STEP 2-High [Tub]free). When entrapped in the MT wall, Syn 
promotes MT catastrophes probably inducing changes in intra- or inter-dimer angles (STEP 2-Low [Tub]free).
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Methods
Protein purification. Tubulin was purified by two cycles of polymerization/depolymerization in high 
molar Pipes buffer13, suspended in BRB buffer (80 mM K-Pipes, pH 6.9, 2 mM EGTA, 1 mM MgCl2) and stored 
at − 80 °C. Recombinant Syn was produced and purified according to Martinez et al.46, and recombinant RB3-
SLD (kindly gifted by prof. Patrick A. Curmi, Evry University, France) was produced and purified according to 
Charbaut et al.47 (see also Supplementary information). Aliquots of Syn (in 20 mM Hepes, pH 7.4, 100 mM KCl) 
and RB3-SLD (in 10 mM Hepes, pH 7.2,150 mM NaCl) were kept at − 80 °C until needed. Each aliquot was clari-
fied by ultracentrifugation (230000× g at 4 °C for 30 min) immediately before use.
MT self-assembly. The kinetics of tubulin polymerization was followed turbidimetrically at 350 nm in a 
multimode plate reader (Infinite 200Pro, Tecan, Mannedorf, Switzerland) equipped with a temperature controller, 
as previously described48. Tubulin was diluted to different concentrations in standard assembly buffer and kept on 
ice; as WT or mutated Syns were added, the reaction was started by warming the solution at 37 °C. For the prein-
cubation, two solutions were prepared: T1, buffer with 2x glycerol and GTP and w/o proteins, and T2, with double 
of the final protein concentration but w/o glycerol and GTP. T2 was incubated 10 min at 20 °C, and the reaction 
was started mixing T1 and T2 1:1 and raising the temperature to 37 °C. Polymerization time-course was dissected 
and the kinetic parameters calculated according to Bonfils et al.20: P (number of successive steps during nucle-
ation) was determined by plotting log(A(t)/A∞ ) against log(t) and extrapolated as the pendency of the linear 
part of the resulting plot; initial velocity of polymerization (Vi) was calculated as the maximal variation of mass 
versus time (δ A/δ t); MT assembly was deduced from the extent of absorbance variation (Δ A) at the steady-state. 
The x-intercept of the linear dependence of Δ A from the initial tubulin concentration represents the tubulin 
critical concentration. To evaluate MT length and number, 2.7 μ M rhodamine-labelled tubulin (Cytoskeleton, 
Denver, CO) was included in the polymerization solutions and the reaction was stopped by addition of 0.5% 
glutaraldehyde. MTs were laid on slides and their length was measured using a digital image processing software 
(Axiovision, Carl Zeiss, Oberkochen, Germany) to analyse the images acquired with the Axiovert 200 M micro-
scope (Carl Zeiss). To assess the ultrastructure of assembled MTs, samples were fixed with 0.5% glutaraldehyde 
and then placed on Formvar-coated nickel grids, negative stained with uranyl acetate and observed with a Philips 
CM10 transmission electron microscope at 80 kV, equipped with a Morada Olympus digital camera.
Co-sedimentation assay. MTs were polymerized (from tubulin 40 μ M) 20 min at 37 °C, stabilized 10 min 
with paclitaxel (Sigma-Aldrich) and then diluted to 4 μ M. Syn (0.5–32 μ M) was incubated 20 min at 37 °C in 
the absence or in the presence of MTs and then centrifuged at 70000× g for 15 min at 25 °C. Supernatant and 
pellet were loaded on SDS-PAGE, proteins were transferred onto PVDF membranes and immunostained with 
anti-Syn rabbit IgG (Sigma-Aldrich) HRP goat anti-rabbit IgG (Sigma-Aldrich). Immunostaining was revealed 
by enhanced chemiluminescence (Super-Signal West Pico Chemiluminescent, Pierce). Quantification was per-
formed by Image J software (NIH) subtracting the background around bands. According to Ackmann et al.12, 
[Syn]bound was plotted versus [Syn]free and the data fitted by nonlinear regression to a standard binding equation 
(Equation 1) using SigmaPlot (Jandel, CA):
=
+
Syn
B Syn
K Syn
[ ]
[ ]
[ ] (1)
bound
max free
d free
Mass spectrometry. Nano-ESI-MS was performed on a hybrid quadrupole-time-of-flight instrument 
(QSTAR Elite, Applied Biosystems, Foster City, CA) with minor modifications to previously reported conditions49. 
Purified proteins were thawed and buffer exchanged by two cycles of desalting on Micro Bio-Spin™ P-6 Gel columns 
(Bio-Rad laboratories, Hercules, CA), immediately before use. All spectra were acquired in 10 mM ammonium 
acetate after incubation at room temperature for at least 10 min and no longer than 1 h.
Circular dichroism. Circular dichroism spectra were acquired using a Jasco J810 spectropolarimeter. 
Secondary structure of Syn (0.2 mg/ml) and RB3-SLD (0.1 mg/ml), either alone or in the presence of tubu-
lin (1.4 mg/ml), was investigated by recording far-UV circular dichroism spectra in 0.1 cm quartz cuvettes. 
All proteins were dissolved in BRB buffer. Spectra of pure Syn and RB3-SLD were baseline-corrected by sub-
tracting a buffer spectrum, while difference spectra of the Syn/tubulin and RB3-SLD/tubulin mixtures were 
“tubulin-corrected” by subtracting the spectrum of the pure tubulin from those of the mixtures. Syn spectra were 
normalized in terms of mean residual ellipticity by using a mean residue weight of 103 Da. Since BRB buffer does 
not allow to record spectra below 215 nm, the α -helical content was estimated from the mean residual ellipticity 
at 222 nm according to Chen and Yang50.
NMR spectroscopy. The NMR spectra were recorded on a Bruker AV600 spectrometer (Bruker 
Spectrospin AG, Rheinstetten, Germany), operating at 600.10 MHz for the 1H nucleus and equipped with a 
standard triple-resonance probe with z-axis gradients. Temperature control was achieved through the spec-
trometer BVT3000 temperature control unit, using nitrogen gas (flow 270 l/h) pre-cooled with a Bruker BCU20 
refrigeration unit. 1H-NMR chemical shifts (δ ) were measured in ppm, using as reference external sodium 
4,4-dimethyl-2-silapentane-1-sulfonate (DSS) set at 0.00 ppm. DOSY (Diffusion Oriented Spectroscopy) meas-
urements were performed at 25 °C on a freshly prepared 27 μ M solution of tubulin, dissolved in 0.6 ml H2O:D2O 
9:1 (v/v), pH 6.8 50 mM phosphate buffer, in the presence of various amounts of Syn (Syn/tubulin molar ratios 
varied between 0 and 10) after at least 0.5 h incubation. DSS, deuterium oxide (99.8% purity) and 5 mm O.D. NMR 
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tubes (Wilmad 535-PP type) were purchased from Sigma-Aldrich. Solvent suppression was achieved by including 
in the DOSY pulse-sequence a WATERGATE pulse-scheme51. A gradient-based stimulated echo bipolar pulse 
sequence was utilized52, with a 0.3 s diffusion delay (“big delta”) and a 1.5 ms gradient pulse length (“little delta”). 
32 one-dimensional spectra were collected with a gradient strength varying between 0.67 and 33.4 Gauss/cm. 
Values for “little delta” and “big delta” parameters were chosen by taking into account also the expected short 
transverse relaxation rates due to the formation of high molecular weight aggregates. Other relevant acquisition 
parameters: time-domain: 2 K; number of scans: 196; relaxation delay: 2 s. Raw data were Fourier-transformed 
after apodization with a 90°-shifted sine-bell-squared function and baseline corrected. Log(D) values were 
derived by a two-components non-linear fitting and displayed as pseudo-2D spectra.
Limiting values for the molar fraction of free Syn (α ) were estimated from the experimental diffusion coeffi-
cients (D, Equation 2) as:
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where Dsyn is the experimental value determined for free Syn. Dtub:syn and Dtub2:syn are the D values expected for 
complexes formed by Syn with α β tubulin dimer and α 2β 2 tubulin tetramer, respectively. These last values were 
estimated by applying the following correction factors to Dtub:
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The dissociation constant Kd of Syn-tubulin complex was derived by applying the following equation 5:
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where Dbound can be either Dtub:syn or Dtub2:syn as derived from equation 3 and 4.
Video-microscopy and data analysis. MTs were assembled from purified axonemes with tubulin (10–15 μ M) 
and increasing concentrations of preincubated Syn (5–15 μ M). Samples were prepared in perfusion chambers, 
previously saturated with 50 μ M Syn, and observed at 37 °C with an Olympus BX-51 microscope equipped with 
DIC prisms and a video camera coupled to an Argus 20 image processor (Hamamatsu, Hamamatsu City, Japan), 
as previously described53. Images were recorded every 2 s over periods of 5 min. The total recording time did not 
exceed 60 min for each chamber. Measurements of MT dynamics and data analysis were carried out using Image 
J (NIH, Bethesda, MD) and Kaleidagraph (Synergy Software Systems, Dubai, UAE), as previously described53.
Immunoblotting and live cell imaging. PC12 cells were maintained in cultures and differentiated as 
previously described39. PC12 cells were transiently transfected using Lipofectamine 2000 (Invitrogen), with 
C-terminal GFP-fused human WT Syn or with GFP-containing control vector (eGFP-N1). Whole cell extracts 
were loaded on SDS-PAGE, transferred onto PVDF membranes and immunostained with anti-Syn rabbit IgG 
and anti-GAPDH as loading control. For live cell imaging experiments, GFP-WT Syn and GFP-containing vec-
tors were co-transfected with EB3-mCherry construct24 (kindly provided by Dr Galjart, Medical Genetic Center, 
Erasmus University, Rotterdam, The Netherlands). As previously described39, cultures were transferred to a live 
cell imaging workstation; images were collected every 6 s with a cooled camera (Axiocam HRM Rev. 2; Zeiss) 
for periods of 3-4 min, and the total recording time did not exceed 60 min for each dish. MT growth dynamics 
was automatically analysed using plusTipTracker software54. The area of the analysed neurites was estimated by 
ImageJ software (Supplementary Fig. S6).
Protein alignment. Pairwise alignments between Syn and stathmin sequences were made using Pam250 or 
Bl50 matrix, whereas multiple protein alignment was performed with ClustalW software.
Statistical analyses. For multiple comparisons, the statistical significance of treatment was assessed by 
one-way ANOVA with Dunnett 2-sided or Fischer LSD post-hoc testing, whereas differences between WT Syn 
and controls were assessed using Student’s t-test. All analyses were performed using STATISTICA (StatSoft Inc., 
Tulsa, OK).
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